CRISPR Therapeutics AG
NASDAQ:CRSP
Intrinsic Value
The intrinsic value of one
CRSP
stock under the Base Case scenario is
6.686
USD.
Compared to the current market price of 56.045 USD,
CRISPR Therapeutics AG
is
Overvalued by 88%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for CRISPR Therapeutics AG.
Fundamental Analysis
Revenue & Expenses Breakdown
CRISPR Therapeutics AG
Earnings Waterfall
CRISPR Therapeutics AG
The intrinsic value of one
CRSP
stock under the Base Case scenario is
6.686
USD.
Compared to the current market price of 56.045 USD,
CRISPR Therapeutics AG
is
Overvalued by 88%.